%0 Journal Article
%T Anti-IL-23 treatment with tildrakizumab can be effective in omalizumab-refractory chronic spontaneous urticaria: A case series.
%A Bonnekoh H
%A Kiefer L
%A Buttgereit T
%A Kolkhir P
%A Lütke-Eversloh M
%A Scheffel J
%A Maurer M
%A Metz M
%J J Allergy Clin Immunol Pract
%V 11
%N 8
%D 2023 08 25
%M 37244440
暂无%R 10.1016/j.jaip.2023.05.019